2-(Cyclopent-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane → 5-Cyclopent-1-enyl-6-(2,2,2-trifluoro-ethoxy)-nicotinic acid methylester
Reaction equation
[CH3:1][O:2][C:3]([C:5]1[CH:6]=[N:7][C:8]([O:12][CH2:13][C:14]([F:17])([F:16])[F:15])=[C:9](Br)[CH:10]=1)=[O:4].[C:18]1(B2OC(C)(C)C(C)(C)O2)[CH2:22][CH2:21][CH2:20][CH:19]=1>>[CH3:1][O:2][C:3]([C:5]1[CH:6]=[N:7][C:8]([O:12][CH2:13][C:14]([F:17])([F:16])[F:15])=[C:9]([C:18]2[CH2:22][CH2:21][CH2:20][CH:19]=2)[CH:10]=1)=[O:4]Participants
3
Procedure
The title compound was synthesized in analogy to Example 12a using 5-bromo-6-(2,2,2-trifluoroethoxy)-3-pyridinecarboxylic acid methyl ester (CAN 1211589-51-3) and 2-(1-cyclopenten-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAN 287944-10-9) as starting materials; MS (EI) 302.0 (M+H)+.
Sources & evidence
- ORD record
- ord-a27a734bc7014049b1e3ade82db9f9cd
- Source dataset
- uspto-grants-2014_02
- Patent number
- US08648099B2
Reaction notes
Loading…